The article discusses collaboration between competing companies to redesign and promote innovation of an entire industry, focusing on a meeting held in 2013 in Madrid, Spain of pharmaceutical industry interests, investors, and government representatives to create an improved drug discovery model. The suggestions produced by the group include decentralization of drug development to independent producers, research data sharing, and greater transparency.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados